KALA BIO, Inc.
KALA
$3.75
$0.030.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.13% | -11.15% | -13.00% | -10.08% | -20.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26% | -8.93% | 4.26% | 16.96% | 2.04% |
| Operating Income | -1.26% | 8.93% | -4.26% | -16.96% | -2.04% |
| Income Before Tax | 5.24% | -2.83% | 8.01% | 18.32% | 32.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.24% | -2.83% | 8.01% | 18.32% | 32.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.24% | -2.83% | 8.01% | 18.32% | 32.83% |
| EBIT | -1.26% | 8.93% | -4.26% | -16.96% | -2.04% |
| EBITDA | -1.28% | 8.84% | -4.47% | -17.20% | -2.17% |
| EPS Basic | 45.25% | 43.33% | 27.51% | 39.92% | 60.10% |
| Normalized Basic EPS | 4.56% | 55.01% | 24.70% | 33.26% | 75.18% |
| EPS Diluted | 45.25% | 43.33% | 27.51% | 39.91% | 60.11% |
| Normalized Diluted EPS | 4.56% | 55.01% | 24.70% | 33.26% | 75.18% |
| Average Basic Shares Outstanding | 73.07% | 81.46% | 26.90% | 35.96% | 68.33% |
| Average Diluted Shares Outstanding | 73.07% | 81.46% | 26.90% | 35.96% | 68.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |